Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement

NCT00284050 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Ranibizumab 0.3 mg
DRUG: Ranibizumab 0.5 mg
DRUG: Sham injection

Sponsor

Novartis